| Market Cap | ₹39,897Cr |
| ROE | NA |
| P/E Ratio(TTM) | 88.36 |
| EPS(TTM) | 8.04 |
| P/B Ratio | 16.55 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.63 |
| Book Value | 42.92 |
| Debt to Equity | NA |
| Face Value | 2 |
| Parent Organisation | Anthem Biosciences |
| NSE Symbol | ANTHEM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 75.76 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1687.77 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.74 | ||
| Panacea Biotec | NA (0.00%) | 240.52 |